Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations

European Journal of Endocrinology

Volumn 161, Issue SUPPL. 1, 2009, Pages

  Kołtowska Häggström, Maria ^a   Mattsson, Anders F ^a   Shalet, Stephen M ^b  

^a PFIZER INC   (United States)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; BIOLOGICAL MARKER; SOMATOMEDIN C;

ACROMEGALY; AGE DISTRIBUTION; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL RESEARCH; CRANIOPHARYNGIOMA; CUSHING DISEASE; DATA COLLECTION METHOD; DEMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED PRACTICE; GROWTH HORMONE DEFICIENCY; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; LONG TERM CARE; MEDICAL DECISION MAKING; NOTTINGHAM EXTENDED ACTIVITIES OF DAILY LIVING SCALE; OBESITY; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RADIOTHERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TRAUMATIC BRAIN INJURY; ADULT; AGE; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; DRUG COST; ECONOMICS; EPIDEMIOLOGY; FACTUAL DATABASE; FEMALE; HEALTH CARE PLANNING; INTERNATIONAL COOPERATION; MALE; METABOLISM; MIDDLE AGED; UTILIZATION REVIEW;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATABASES, FACTUAL; DRUG COSTS; FEMALE; HEALTH RESOURCES; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR I; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; QUALITY OF LIFE; SEX FACTORS;

EID: 70450199337     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0266     Document Type: Review

References (74)

1. O'Connor R In Measuring Quality of Life in Health, pp 1-22. Churchill Livingstone: Elsevier Ltd, 2004.
2. Torrance GW. Measurement of health state utilities for economic appraisal. Journal of Health Economics 1986 5 1-30. (Pubitemid 16098443)
3. Carroll PV, Christ ER, and the members of Growth Hormone Research Society Scientific Committee: Bengtsson B-Å, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sönksen PH, Tanaka T & Thorner M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Journal of Clinical Endocrinology and Metabolism 1998 83 382-395.
4. Björk S, Jonsson B, Westphal O & Levin JE. Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatrica Scandinavica 1989 356 55-59. (Pubitemid 19242167)
5. McGauley GA, Cuneo R, Salomon F & Sönksen PH. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Hormone Research 1990 33 52-54. (Pubitemid 20261754)
6. Rosén T, Wirén L, Wilhelmsen L, Wiklund I & Bengtsson B-Å. Decreased psychological well-being in adult patients with growth hormone deficiency. Clinical Endocrinology 1994 40 111-116. (Pubitemid 24193136)
7. Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards EHT & MacFarlane IA. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy up to 3 years. Clinical Endocrinology 1997 47 439-446. (Pubitemid 27452063)
8. Wirén L, Bengtsson B-Å & Johannsson G. Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency. Clinical Endocrinology 1998 48 613-620. (Pubitemid 28252998)
9. Holmes SJ, McKenna SP, Doward LD, Hunt SM & Shalet SM. Development of a questionnaire to assess the quality of life of adults with GHD. Endocrinology and Metabolism 1995 2 63-69.
10. Hunt SM, McKenna SP & Doward LC. Preliminary report on the development of a disease-specific instrument for assessing quality of life of adults with growth hormone deficiency. Acta Endocrinologica 1993 128 37-40.
11. Deijen JB, de Boer H, Blok GJ & van der Veen EA. Cognitive impairments and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology 1996 21 313-322.
12. van Dam PS, de Winter CF, de Vries R, van der Grond J, Drent ML, Lijffijt M, Kenemans JL, Aleman A, de Haan EHF & Koppeschaar HPF. Childhood-onset growth hormone deficiency, cognitive function and brain N-acetylaspartate. Psychoneuroendocrinology 2005 30 357-363. (Pubitemid 40188190)
13. Bülow B, Hagmar L, Ørbæk P, Österberg K & Erfurth EM. High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease. Clinical Endocrinology 2002 56 183-193.
14. Arwert LI, Deijen JB, Witlox J & Drent ML. The influence of growth hormone (GH) substitution on patient-reported outcomes and cognitive functions in GH-deficient patients: a meta-analysis. Growth Hormone and IGF Research 2005 15 47-54. (Pubitemid 40220855)
15. Woodhouse LC, Mukherjee A, Shalet SM & Ezzat S. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocrine Reviews 2006 27 287-317.
16. Mårdh G, Lundin K, Borg G, Jonsson B & Lindeberg A on behalf of the investigators. Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled clinical trials. Endocrinology and Metabolism 1994 1 (Supplement A) 43-49.
17. Attanasio AF, Lamberts SWJ, Matranga AMC, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BÅ & Strasburger CJ the Adult Growth Hormone Deficiency Study Group. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Journal of Clinical Endocrinology and Metabolism 1997 82 82-88.
18. Verhelst J, Abs R, Vandeweghe M, Mockel J, Legros JJ, Copinschi G, Mahler C, Velkeniers B, Vanhaelst L, van Aelst A, de Rijdt D, Stevenaert A & Beckers A. Two years of replacement therapy in adults with growth hormone deficiency. Clinical Endocrinology 1997 47 485-494. (Pubitemid 27452069)
19. Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A & Shimatsu A. Efficacy and safety of GH in the treatment of adult Japanese patients with GHD: a randomized, placebo-controlled study. Growth Hormone and IGF Research 2006 16 132-142. (Pubitemid 44225965)
20. Deijen JB, de Boer H, Blok GJ & van der Veen EA. Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology 1998 23 41-45.
21. Carroll PV, Littlewood R, Weissberger AJ, Bogalho P, McGauley G, Sönksen PH & Russell-Jones DL. The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone deficient adults. European Journal of Endocrinology 1997 137 146-153. (Pubitemid 27342229)
22. Burman P, Broman JE, Hetta J, Wiklund I, Erfurth EM, Hagg E & Karlsson FA. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. Journal of Clinical Endocrinology and Metabolism 1995 80 3585-3590.
23. Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW & Hurley D. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 1998 83 107-116. (Pubitemid 28498319)
24. Beshyah SA, Freemantle C, Shahi M, Anyaoku V, Merson S, Lynch S, Skinner E, Sharp P, Foale R & Johnston DG. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clinical Endocrinology 1995 42 73-84.
25. Baum HBA, Katznelson L, Sherman JC, Biller BMK, Hayden DL, Schoenfeld DA, Cannistraro KE & Klibanski A. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. Journal of Clinical Endocrinology and Metabolism 1998 83 3184-3189. (Pubitemid 28500954)
26. Sathiavageeswaran M, Burman P, Lawrence D, Harris AG, Falleti MG, Maruff P & Wass J. Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebocontrolled 12-month study. European Journal of Endocrinology 2007 156 439-447. (Pubitemid 46672644)
27. Rosilio M, Blum WF, Edwards DJ, Berthezene F, Shavrikova EP, Valle D, Lamberts SWJ, Erfurth EM, Webb SM, Ross RJ, Chihara K, Henrich G, Herschbach P & Attanasio AF. Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on Life Satisfaction-Hypopituitarism (QLS-H). Journal of Clinical Endocrinology and Metabolism 2004 89 1684-1693. (Pubitemid 38514701)
28. Ranke MB. The role of large databases in outcomes research. In GH Replacement in Adults - The First 5 Years in KIMS, pp 1-5. Eds BÅ Bengtsson & JP Monson, Oxford: Oxford PharmaGenesis Ltd, 2000.
29. Gutiérrez LP, Kołtowska-Häggström M, Jönsson PJ, Mattsson AF, Svensson D, Westberg B & Luger A. Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database). Pharmacoepidemiology and Drug Safety 2008 17 90-102. (Pubitemid 351187389)
30. McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L & Wirén L. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Quality of Life Research 1999 8 373-383. (Pubitemid 29369642)
31. Dupuy HJ. The psychological general well-being (PGWB) index. In Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies, pp 170-183. Eds NK Wenger, ME Mattson, CF Furberg & J Elinson, New York: Le Jacq Publishing, 1984.
32. Hunt SM, McKenna SP, McEwen J, Williams J & Papp E. The Nottingham health profile: subjective health status and medical consultations. Social Science and Medicine 1981 15 221-229. (Pubitemid 11082718)
33. EuroQoL Group. EuroQoL - a new facility for the measurement of health-related quality of life. Health Policy 1990 16 19-208.
34. Saller B, Mattsson AF, Kann PH, Koppeschaar HP, Svensson J, Pompen M & Kołtowska-Häggström M. Healthcare utilization, quality of life and patient-reported outcomes during two years of growth hormone (GH) replacement therapy in GH-deficient adults - comparison between Sweden, The Netherlands and Germany. European Journal of Endocrinology 2006 154 843-850. (Pubitemid 43997723)
35. Hunt SM & McKenna SP. The QLDS: a scale for the measurement of quality of life in depression. Health Policy 1992 22 307-319.
36. Kołtowska-Häggström M, Hennessy S, Mattsson AF, Monson JP & Kind P. Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England andWales with results for adult hypopituitary patients with growth hormone deficiency. Hormone Research 2005 64 46-54. (Pubitemid 41213298)
37. Kołtowska-Häggström M, Mattsson AF, Monson JP, Kind P, Badia X, Casanueva FF, Busschbach J, Koppeschaar HPF & Johannsson G. Does long-term growth hormone replacement therapy in hypopituitary adults with growth-hormone deficiency normalise quality of life? European Journal of Endocrinology 2006 155 109-119.
38. Kołtowska-Häggström M, Kind P, Monson JP & Jonsson B. Growth hormone replacement in hypopituitary adults with growth hormone deficiency evaluated by a utility-weighted quality of life index: a precursor to cost-utility analysis. Clinical Endocrinology 2008 68 122-129.
39. Badia X, Lucas A, Sanmarti A, RosetM& Ulied A. One-year followup of quality of life in adults with untreated growth hormone deficiency. Clinical Endocrinology 1998 49 765-771. (Pubitemid 29009506)
40. Wirén L, Whalley D, McKenna SP & Wilhelmsen L. Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone deficient adults and a random population sample in Sweden: validation of the measure by Rasch analysis. Clinical Endocrinology 2000 52 143-152. (Pubitemid 30108259)
41. Kołtowska-Häggström M, Jonsson B, Isacson D & Bingefors K. Using EQ-5D to derive general population-based utilities for the quality of life-assessment of growth hormone deficiency in adults (QoL-AGHDA). Value in Health 2007 10 73-81. (Pubitemid 46164755)
42. McKenna SP & Hunt S. The general well-being index: adapting and re-testing an American measure for use in the United Kingdom. British Journal of Medical Economics 1992 4 41-50.
43. Hernberg-Ståhl E, Luger A, Abs R, Bengtsson BÅ, Feldt-Rasmussen U, Wilton P, Westberg B & Monson JP. Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism 2001 86 5277-5281. (Pubitemid 33072095)
44. Abs R, Bengtsson BÅ, Hernberg-Ståhl E, Monson JP, Tauber JP, Wilton P & Wüster C. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clinical Endocrinology 1999 50 703-713. (Pubitemid 29284503)
45. Bengtsson B-Å, Abs R, Bennmarker H, Monson JP, Feldt-Rasmussen U, Hernberg-Ståhl E, Westberg B, Wilton P & Wüster C. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 1999 54 3929-3936.
46. Monson JP, Abs R, Bengtsson B-Å, Bennmarker H, Feldt-Rasmussen U, Hernberg-Ståhl E, Thoren M, Westberg B, Wilton P & Wüster C. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database. Clinical Endocrinology 2000 53 281-289.
47. Svensson J, Mattsson A, Rosén T, Wirén L, Johansson G, Bengtsson B-Å & Kołtowska-Häggström M. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption. Growth Hormone and IGF Research 2004 4 207-215. (Pubitemid 38691043)
48. Moock J, Albrecht C, Friedrich N, Völzke H, Nauck M, Koltowska- Häggström M, Kohlmann T & Wallaschofski H. Health-related quality of life and IGF-I in growth hormone deficient adult patients on growth hormone replacement therapy: analysis of the german KIMS data and the study of health in pomerania (SHIP). European Journal of Endocrinology 2009 160 17-24.
49. Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P & Wüster C. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly and Cushing's. European Journal of Endocrinology 2002 146 67-74. (Pubitemid 34130119)
50. Kendall-Taylor P, Jönsson PJ, Abs R, Erfurth EM, Kołtowska-Häggström M, Price DA & Verhelst J. The clinical, metabolic, endocrine features and quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. European Journal of Endocrinology 2005 152 557-567. (Pubitemid 40575801)
51. Verhelst J, Kendall-Taylor P, Erfurth EM, Price DA, Geffner M, Kołtowska-Häggström M, Jönsson PJ, Wilton P & Abs R. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with non-functioning pituitary adenoma: data from KIMS (Pfizer International Database). Journal of Clinical Endocrinology and Metabolism 2005 90 4636-4643. (Pubitemid 41166526)
52. Höybye C, Jönsson P, Monson JP, Kołtowska- Häggström M, Hána V, Geffner M & Abs R. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset growth hormone deficiency. European Journal of Endocrinology 2007 157 589-596. (Pubitemid 350187375)
53. Monson JP & Jönsson P. Aspects of growth hormone (GH) replacement in elderly patients with GH deficiency: data from KIMS. Hormone Research 2003 55 (Supplement 1) 112-120. (Pubitemid 37107337)
54. Abs R, Mattsson AF, Bengtsson B-Å, Feldt-Rasmussen U, Goth MI, Koltowska-Haggstrom M, Monson JP, Verhelst J & Wilton P. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Hormone and IGF Research 2005 15 349-359. (Pubitemid 41408413)
55. Siyambalapitiya S, Jonsson P, Koltowska-Haggstrom M, Gaillard R, Ho K & Ross RJM. A cross-sectional analysis of testosterone therapies in hypopituitary men on stable pituitary hormone replacement. Clinical Endocrinology 2009 70 907-913.
56. Maiter D, Abs R, Johannsson G, Scanlon M, Jönsson PJ, Wilton P & Kołtowska-Häggström M. Baseline characteristics and response to growth hormone (GH) replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from KIMS (Pfizer International Metabolic Database). European Journal of Endocrinology 2006 155 253-260. (Pubitemid 44269441)
57. Keleştimur F, Jönsson P, Molvalilar S, Gomez JM, Auernhammer CJ, Colak R, Kołtowska-Häggström M & Góth MI. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database. European Journal of Endocrinology 2005 152 581-587.
58. Casanueva FF, Leal A, Kołtowska-Häggström M, Jönsson P & Góth MI. Traumatic brain injury (TBI) as a relevant cause of GHD in adults: a KIMS-based study. Archives of Physical Medicine and Rehabilitation 2005 86 463-468. (Pubitemid 40326627)
59. Kreitschmann-Andermahr I, Poll EM, Reineke A, Gilsbach JM, Brabant G, Buchfelder M, Fassbender W, Faust M, Kann PH & Wallaschofski H. Growth hormone deficient patients after traumatic brain injury - baseline characteristics and benefits after growth hormone replacement - an analysis of the German KIMS database. Growth Hormone and IGF Research 2008 18 472-478.
60. Abrams P, Boquete H, Fideleff H, Feldt-Rasmussen U, Jönsson PJ, Koltowska-Häggström M, Wilton P & Abs R. Growth hormone replacement in hypopituitarism improves lipid profile and quality of life independently of changes in obesity variables. European Journal of Endocrinology 2008 159 825-832.
61. Hürny C, Bernhard J, Gelber RD, Coates A, Castiglione M, Isley M, Dreher D, Peterson H, Goldhirsch A & Senn HJ for the International Breast Cancer Study Group. Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. European Journal of Cancer 1992 28 118-124.
62. Inglehart R & Rabier JR. Aspirations to adapt to situations but why are Belgians so much happier than the French? A cross-cultural analysis of the subjective quality of life. In Research on the Quality of Life, pp 1-56. Ed. FM Andrews. Ann Arbor Institute for Social Research, University of Michigan, 1986.
63. Blum WF, Shavrikova EP, Edwards DJ, Rosilio M, Hartman M, Marin F, Valle D, van der Lely AJ, Attanasio AF, Strasburger CJ, Henrich G & Herschbach P. Decreased quality of life in adult patients with growth hormone deficiency compared with general populations using the new, validated, self-weighted questionnaire, questions on life satisfaction hypopituitarism module. Journal of Clinical Endocrinology and Metabolism 2003 88 4158-4167. (Pubitemid 37158032)
64. Hakkaart-van Roijen L, Beckers A, Stevenaert A & Rutten FF. The burden of illness of hypopituitary adults with growth hormone deficiency. PharmacoEconomics 1998 14 395-403. (Pubitemid 28455687)
65. Sanmarti A, Lucas A, Hawkins F, Webb SM & Ulied A On behalf of the collaborative ODA (Observational GH Deficiency in Adults). Group observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study). European Journal of Endocrinology 1999 141 481-489.
66. Ehrnborg C, Hakkaart-Van Roijen L, Jonsson B, Rutten FFH, Bengtsson BÅ & Rosén T. Cost of illness in adult patients with hypopituitarism. PharmacoEconomics 2000 17 621-628. (Pubitemid 30407886)
67. Coast J. Is economic evaluation in touch with society's health values? BMJ 2004 329 1233-1236.
68. Torrance GW. Utility approach to measuring health-related quality of life. Journal of Chronic Diseases 1987 40 593-600.
69. Torrance GW. Health status index models: a unified mathematical view management. Science 1976 22 990-1001.
70. Dixon S, McEwan P & Currie CJ. Estimating the health utility of treatment in adults with growth hormone deficiency. Journal of Outcomes Research 2003 7 1-12. (Pubitemid 36988299)
71. Black N. What observational studies can offer decision makers. Hormone Research 1999 51 44-49. (Pubitemid 29301283)
72. Kahn MG. Clinical research databases and clinical decisison making in chronic diseases. Hormone Research 1999 51 50-57.
73. Wilton P. Foreword. European Journal of Endocrinology 2009 161 S1-S2.
74. Ho KY and on behalf of the 2007. GH Deficiency Consensus Workshop Participants. Consensus Guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Paediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology 2007 157 695-700.